Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.890
+0.070 (3.85%)
Aug 11, 2025, 2:09 PM - Market open
The Aaron's Company Market Cap
Entera Bio has a market cap or net worth of $85.90 million as of August 11, 2025. Its market cap has increased by 33.18% in one year.
Market Cap
85.90M
Enterprise Value
72.07M
1-Year Change
33.18%
Ranking
Category
Stock Price
$1.89
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.77M to $85.90M, an increase of 19.69%. That is a compound annual growth rate of 2.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 82.72M | 5.94% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | 19.83M | -23.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |